Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond
Mengting Li, Muhsin H. Younis, Yongxue Zhang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 8, pp. 2844-2868
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Biomarker-driven molecular imaging probes in radiotherapy
Haonan Li, Qiyong Gong, Kui Luo
Theranostics (2024) Vol. 14, Iss. 10, pp. 4127-4146
Open Access | Times Cited: 79
Covalent targeted radioligands potentiate radionuclide therapy
Xi‐Yang Cui, Zhu Li, Ziren Kong, et al.
Nature (2024) Vol. 630, Iss. 8015, pp. 206-213
Closed Access | Times Cited: 54
Theranostic Nuclear Medicine with Gallium-68, Lutetium-177, Copper-64/67, Actinium-225, and Lead-212/203 Radionuclides
Katherine A. Morgan, Stacey E. Rudd, Asif Noor, et al.
Chemical Reviews (2023) Vol. 123, Iss. 20, pp. 12004-12035
Closed Access | Times Cited: 43
PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using68Ga-FAP-2286: Comparison with18F-FDG and68Ga-FAPI-46 in a Single-Center, Prospective Study
Yizhen Pang, Liang Zhao, Tinghua Meng, et al.
Journal of Nuclear Medicine (2022) Vol. 64, Iss. 3, pp. 386-394
Open Access | Times Cited: 61
Recent Trends in Diagnostic Biomarkers of Tumor Microenvironment
Paniz Siminzar, Mohammad Reza Tohidkia, Elisabeth Eppard, et al.
Molecular Imaging and Biology (2022) Vol. 25, Iss. 3, pp. 464-482
Closed Access | Times Cited: 55
Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics—Where We Are at and Where We Are Heading: A Systematic Review
Marko Magdi Abdou Sidrak, Maria Silvia De Feo, Ferdinando Corica, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3863-3863
Open Access | Times Cited: 24
Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides
Richard P. Baum, Emil Novruzov, Tianzhi Zhao, et al.
Seminars in Nuclear Medicine (2024) Vol. 54, Iss. 4, pp. 537-556
Closed Access | Times Cited: 11
Fibroblast activation protein inhibitor-positron emission tomography in aortitis: fibroblast pathology in active inflammation and remission
Manuel Röhrich, Juan José Rosales, Jorge Hoppner, et al.
Lara D. Veeken (2024) Vol. 63, Iss. 9, pp. 2473-2483
Closed Access | Times Cited: 9
Fibroblast Activation Protein Inhibitor Tracers and Their Preclinical, Translational, and Clinical Status in China
Liang Zhao, Fei Kang, Yizhen Pang, et al.
Journal of Nuclear Medicine (2024) Vol. 65, Iss. Supplement 1, pp. 4S-11S
Closed Access | Times Cited: 9
FAP-targeted delivery of radioiodinated probes: A progressive albumin-driven strategy for tumor theranostics
Huifeng Li, Dongsheng Xia, Lingxin Meng, et al.
Journal of Controlled Release (2025), pp. 113678-113678
Closed Access | Times Cited: 1
Current research topics in FAPI theranostics: a bibliometric analysis
Andor F. van den Hoven, Ruth G.M. Keijsers, Marnix G. E. H. Lam, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 50, Iss. 4, pp. 1014-1027
Closed Access | Times Cited: 29
The Superiority of Fibroblast Activation Protein Inhibitor (FAPI) PET/CT Versus FDG PET/CT in the Diagnosis of Various Malignancies
Yanzhao Dong, Haiying Zhou, Ahmad Alhaskawi, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1193-1193
Open Access | Times Cited: 22
The roles of proteases in prostate cancer
Hannu Koistinen, Ruusu‐Maaria Kovanen, Morley D. Hollenberg, et al.
IUBMB Life (2023) Vol. 75, Iss. 6, pp. 493-513
Open Access | Times Cited: 21
Clinical Translation of Targeted α-Therapy: An Evolution or a Revolution?
Benedikt Feuerecker, Clemens Kratochwil, Hojjat Ahmadzadehfar, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 5, pp. 685-692
Open Access | Times Cited: 17
Cancer-associated fibroblasts promote proliferation, angiogenesis, metastasis and immunosuppression in gastric cancer
Peiyuan Li, Huan Zhang, Tao Chen, et al.
Matrix Biology (2024) Vol. 132, pp. 59-71
Open Access | Times Cited: 8
Peptidic heterodimer-based radiotracer targeting fibroblast activation protein and integrin αvβ3
Kehuang Liu, Tao Jiang, Wanqian Rao, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 6, pp. 1544-1557
Closed Access | Times Cited: 7
Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica
Kornelis S. M. van der Geest, Maria Sandovici, P. H. Nienhuis, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 27
The role of [99mTc]Tc-HFAPi SPECT/CT in patients with malignancies of digestive system: first clinical experience
Xi Jia, Xinru Li, Bing Jia, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 50, Iss. 4, pp. 1228-1239
Open Access | Times Cited: 24
Fibroblast activation protein as a potential theranostic target in brain metastases of diverse solid tumours
Michal Zubaľ, B Vymolová, Ivana Matrasová, et al.
Pathology (2023) Vol. 55, Iss. 6, pp. 806-817
Open Access | Times Cited: 16
Bone Metastasis in Prostate Cancer: Bone Scan Versus PET Imaging
Nasibeh Mohseninia, Nazanin Zamani-Siahkali, Sara Harsini, et al.
Seminars in Nuclear Medicine (2023) Vol. 54, Iss. 1, pp. 97-118
Open Access | Times Cited: 16
Beyond Small Molecules: Antibodies and Peptides for Fibroblast Activation Protein Targeting Radiopharmaceuticals
Xiaona Sun, Yuxuan Wu, Xingkai Wang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 345-345
Open Access | Times Cited: 6
Advances in macrocyclic chelators for positron emission tomography imaging
Mengting Li, Sheng Wang, Qunshou Kong, et al.
View (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 13
Value of [18F]AlF-NOTA-FAPI-04 PET/CT for differential diagnosis of malignant and various inflammatory lung lesions: comparison with [18F]FDG PET/CT
Kailin Qiao, Xueting Qin, Shuai Fu, et al.
European Radiology (2023) Vol. 34, Iss. 3, pp. 1948-1959
Closed Access | Times Cited: 13
Immunotheranostic target modules for imaging and navigation of UniCAR T-cells to strike FAP-expressing cells and the tumor microenvironment
Liliana R. Loureiro, Lydia Hoffmann, Christin Neuber, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 13
Oncologic Staging with68Ga-FAPI PET/CT Demonstrates a Lower Rate of Nonspecific Lymph Node Findings Than18F-FDG PET/CT
Tristan T. Demmert, Kelsey L. Pomykala, Helena Lanzafame, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 12, pp. 1906-1909
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top